MAS1L and metabolic dysfunction-associated steatohepatitis: Although FA, DG, and CER were previously reported to play a role in the pathophysiology of MASH (28, 29), in our cohort, we did not find increased serum levels in patients with MASH compared to MASL (supplemental Figs. S1 and S2).